Last updated: 12/26/2019 10:40:04

GSK study ID
108288
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title:
Trial description:
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
2008-29-07
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Not applicable
Medical condition
Infections, Papillomavirus
Product
SB580299
Collaborators
Not applicable
Study date(s)
December 2006 to July 2008
Type
Observational
Phase
Not applicable

Participation criteria

Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable

Trial location(s)

Location
Status
Contact us
Contact us
Location
GSK Investigational Site
Almada, Portugal, 2805-267
Status
Study Complete
Location
GSK Investigational Site
Amadora, Portugal, 2720-276
Status
Study Complete
Location
GSK Investigational Site
Athens, Greece, 11521
Status
Study Complete
Location
GSK Investigational Site
Athens, Greece, 11522
Status
Study Complete
Location
GSK Investigational Site
Athens, Greece, 11528
Status
Study Complete
Location
GSK Investigational Site
BUCHAREST, Romania
Status
Study Complete
Location
GSK Investigational Site
Bergen, Norway, 5053
Status
Study Complete
Location
GSK Investigational Site
Berlin, Berlin, Germany, 12200
Status
Study Complete
Location
GSK Investigational Site
Brno, Czech Republic, 656 53
Status
Study Complete
Location
GSK Investigational Site
Bruxelles, Belgium, 1070
Status
Study Complete
Location
GSK Investigational Site
Budapest, Hungary, 1032
Status
Study Complete
Location
GSK Investigational Site
Cardiff, United Kingdom, CF14 4XN
Status
Study Complete
Location
GSK Investigational Site
Cluj-Napoca, Romania, 400015
Status
Study Complete
Location
GSK Investigational Site
Coimbra, Portugal, 3000-075
Status
Study Complete
Location
GSK Investigational Site
Edegem, Belgium, 2650
Status
Study Complete
Location
GSK Investigational Site
Edinburgh, Midlothian, United Kingdom, EH16 4SA
Status
Study Complete
Location
GSK Investigational Site
Erlangen, Bayern, Germany, 91054
Status
Study Complete
Location
GSK Investigational Site
Gent, Belgium, 9000
Status
Study Complete
Location
GSK Investigational Site
Hamburg, Hamburg, Germany, 20246
Status
Study Complete
Location
GSK Investigational Site
Hvidovre, Denmark, 2650
Status
Study Complete
Location
GSK Investigational Site
Iasi, Romania
Status
Study Complete
Location
GSK Investigational Site
Krakow, Poland, 31-501
Status
Study Complete
Location
GSK Investigational Site
Leipzig, Sachsen, Germany, 04109
Status
Study Complete
Location
GSK Investigational Site
Lisboa, Portugal, 1069-089
Status
Study Complete
Location
GSK Investigational Site
Liège, Belgium, 4000
Status
Study Complete
Location
GSK Investigational Site
Lublin, Poland, 20-081
Status
Study Complete
Location
GSK Investigational Site
Luebeck, Schleswig-Holstein, Germany, 23538
Status
Study Complete
Location
GSK Investigational Site
Mainz, Rheinland-Pfalz, Germany, 55131
Status
Study Complete
Location
GSK Investigational Site
Miskolc, Hungary, 3529
Status
Study Complete
Location
GSK Investigational Site
Muenchen, Bayern, Germany, 80337
Status
Study Complete
Location
GSK Investigational Site
Muenchen, Bayern, Germany, 80637
Status
Study Complete
Location
GSK Investigational Site
Muenchen, Bayern, Germany, 81675
Status
Study Complete
Location
GSK Investigational Site
Nordhausen, Thueringen, Germany, 99734
Status
Study Complete
Location
GSK Investigational Site
Odense C, Denmark, 5000
Status
Study Complete
Location
GSK Investigational Site
Oslo, Norway
Status
Study Complete
Location
GSK Investigational Site
Ostrava - Poruba, Czech Republic, 708 52
Status
Study Complete
Location
GSK Investigational Site
Patra, Greece, 26335
Status
Study Complete
Location
GSK Investigational Site
Porto, Portugal, 4200-072
Status
Study Complete
Location
GSK Investigational Site
Praha 5, Czech Republic, 154 00
Status
Study Complete
Location
GSK Investigational Site
Szolnok, Hungary, 5004
Status
Study Complete
Location
GSK Investigational Site
Thessaloniki, Greece, 54642
Status
Study Complete
Location
GSK Investigational Site
Thessaloniki, Greece, 57001
Status
Study Complete
Location
GSK Investigational Site
Trondheim, Norway, 7006
Status
Study Complete
Location
GSK Investigational Site
Wolfsburg, Niedersachsen, Germany, 38440
Status
Study Complete

Study documents

Clinical study report
Available language(s): English

If you wish to request for full study report, please contact - [email protected]

Results overview

Refer to study documents

Recruitment status
Study complete
Actual primary completion date
2008-29-07
Actual study completion date
2008-29-07

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website